Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Evogene to Present at LD 500 Virtual Conference
11:00am, Wednesday, 19'th Aug 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments including ag-biologicals
Evogene: Hidden Gems Of Computational Predictive Biology, Part 1 Of 4 (Biomica, Microbiome Therapeutics)
08:55pm, Thursday, 13'th Aug 2020
Evogene Ltd. has developed a unique Computational Predictive Biology platform, leveraging big data and artificial intelligence to life-science products such as microbes, small molecules and genes.
LD Micro Announces Preliminary List of Presenters for the LD 500.
03:37pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Evogene Reports Second Quarter 2020 Financial Results
11:00am, Wednesday, 05'th Aug 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its fin
Evogene to Present at Jefferies Virtual 2020 Industrials Conference
11:00am, Wednesday, 29'th Jul 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading artificial intelligence company targeting to revolutionize life-science product development across several market segments utilizing computationa
Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2020
11:00am, Wednesday, 15'th Jul 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announces today that it
Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing
11:00am, Wednesday, 03'rd Jun 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its par
Evogene Posts Q1 Results, Suffers 67% YoY Revenue Decline
07:31pm, Tuesday, 26'th May 2020Evogene Reports First Quarter 2020 Financial Results
11:00am, Tuesday, 26'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its fin
Evogene Launches Its New Branding to Reflect the Company's Expanded Vision and New Business Model
11:00am, Wednesday, 20'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announces today its reb
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2020
11:00am, Thursday, 07'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries by utilizing cutting edge compu
Evogene Sends Letter to Shareholders, Colleagues, Business Partners
11:35am, Tuesday, 05'th May 2020Evogene Publishes Letter to Shareholders
11:00am, Tuesday, 05'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, by utilizing cutting edge comp
Evogene Files Annual Report for the Year Ended December 31, 2019
11:00am, Thursday, 30'th Apr 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, announced today that it has filed
